Provider review
MintRx review
Its sermorelin headline understates the real monthly price by 16%.
MintRx's own sermorelin page headlines "From $295," then discloses "Billed and shipped monthly. $343 per month" further down the same page — a real, disclosed $48/mo gap once a reader reads the whole page, not a hidden one.
Transparency scorecard
2 of 4 disclosed openly
What MintRx discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
What it actually costs
What they advertise
Sermorelin "From $295"; PT-141 "$160 first month, then $180/mo"; NAD+ "$195 first month, $225/mo after" (or $585 billed quarterly for a 3-month plan).
What you actually pay, month to month
Sermorelin's real, billed-and-shipped-monthly rate is $343/mo, disclosed on the same page as the "From $295" headline. PT-141's real standing rate is $180/mo. NAD+'s real standing rate is $225/mo, both disclosed transparently beside their first-month figures.
The commitment trap
Sermorelin's "From $295" headline sits $48/month (16%) below the "$343 per month" figure the same page discloses as the real, billed-and-shipped-monthly rate.
Checked live on MintRx's own site at https://www.mintrx.com/sermorelin in August 2026. Prices change without notice — confirm before you buy. Every figure here was read off MintRx's own public pages on the date shown, not from a third-party comparison table.
The bottom line
MintRx (mintrx.com) is a real, high-volume telehealth pharmacy storefront (2,000+ Trustpilot reviews) selling compounded PT-141, sermorelin, and NAD+ — no compounded-tirzepatide or compounded-semaglutide price could be independently confirmed this round, so this review covers those three compounds only.
MintRx appears on our sermorelin provider ranking, our NAD+ provider ranking and our PT-141 provider ranking. Nothing on this page is a performance claim.
Who it is for, and who it is not
A good fit if
- You want a dispensing pharmacy named directly, not just a generic "licensed pharmacy" claim.
- You want a LegitScript seal you can independently verify resolves, not just a badge image.
- You want a specific, positive state-availability list rather than a vague nationwide claim.
Look elsewhere if
- You want the headline price to BE the standing price — MintRx's sermorelin and PT-141 headlines both step up after the first month.
- You want a stated 503A/503B regulatory category — MintRx names its pharmacy but never states a category for it.
- You want every legal/contact detail on the site to hold together — its own Contact page names a UK office address on an otherwise entirely US-facing site.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what MintRx bundles in, and what it does not.
Clinician consult
Included
— "prescription medication only available if prescribed after an online consultation with a healthcare provider," per its own site.
Bloodwork / labs
Not stated on the pages checked.
Follow-ups and dose changes
Not stated on the pages checked.
Human support
Not stated on the pages checked.
Injection supplies
Not stated on the pages checked.
Shipping
Not stated on the pages checked.
Also sells
Beyond what this board tracks, MintRx's own site names these additional compounds — read live off the same product pages, not inferred.
- PT-141$160 first month, then $180/mo
- NAD+ Injection$195 first month, $225/mo after
Who fills it, and who's watching
The pharmacy
Unknown regulatory category. MintRx's own footer names a specific dispensing pharmacy via a BBB Business Review seal — "Medmetrics Compounding Pharmacy" (Chandler, AZ) — plus a LegitScript seal (ID 1056826, independently confirmed live at static.legitscript.com, HTTP 200) — but neither "503A" nor "503B" is stated anywhere on the site checked.
Oversight
Included — "prescription medication only available if prescribed after an online consultation with a healthcare provider," per its own site. Not stated on the pages checked.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not.
Where you can get it
List published. The state dropdown on MintRx's own PT-141 intake form lists 34 states plus DC — a real, specific, positive list, not an "all 50" claim.
The honest cons
The part they would rather you skipped
MintRx's own sermorelin page headlines "From $295," undermining the real "$343 per month" standing rate the same page discloses further down — a $48/mo, 16% gap. Its own live Contact page also names a UK office address ("2281 New Way Street, London, United Kingdom") on an otherwise entirely US-facing site (US state dropdown, US phone numbers, US pharmacy) — an unresolved discrepancy this review could not independently explain. No FDA warning letter was found for "MintRx" — checked directly, clean.
- The "From $295" sermorelin headline understates the real $343/mo standing rate by 16%.
- No 503A/503B category is stated anywhere on the site, despite naming its pharmacy.
- Its own Contact page names a UK office address that does not match the rest of the site's entirely US-facing presentation.
None of this is unique to MintRx — the whole category shares it.
How it compares
The providers we rank on our PT-141 provider ranking — the most specific board MintRx sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.
- TRTelos RxA specific, sourced state-exclusion list — next to an unconfirmed "compare" price.
- SRSynergy RxSells no GLP-1 at all — and its own legal terms undercut its "all 50 states" marketing.
- RXRxPepsDirectNo subscription — a per-visit fee, but it can't refund the medication charge.
- EHEOS HealthNames five 503A pharmacies — but its own legal pages disagree on HIPAA.
- YOYourHealthRxDiscloses a first-month promo — but its own homepage still quotes it as standing.
- EDEdgeRxIts GLP-1 category is headlined "From $49/mo" — tirzepatide costs 6x that.
- CECeliaRxA "$350/mo" figure is a $699 vial amortized over a supply length that varies.
- BHBodybuilding Health+Its own sermorelin "discount" plan costs more than paying month-to-month.
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect MintRx's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on MintRx's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.